Smartleaf Asset Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Smartleaf Asset Management’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.12K	Sell	27 -9	-25%	-$416	﹤0.01%	3099
2025 Q4	$1.64K	Sell	36 -4,852	-99%	-$215K	﹤0.01%	3042
2025 Q3	$187K	Buy	4,888 +1	+0%	+$36	0.01%	758
2025 Q2	$164K	Buy	4,887 +1,154	+31%	+$36.5K	0.01%	648
2025 Q1	$125K	Buy	3,733 +582	+18%	+$22.1K	0.01%	744
2024 Q4	$122K	Buy	3,151 +316	+11%	+$13.3K	0.01%	750
2024 Q3	$126K	Buy	2,835 +59	+2%	+$2.64K	0.02%	637
2024 Q2	$117K	Sell	2,776 -34	-1%	-$1.42K	0.02%	530
2024 Q1	$128K	Buy	2,810 +109	+4%	+$4.96K	0.02%	463
2023 Q4	$127K	Buy	+2,701	New	+$110K	0.03%	387

Other funds holding GNOM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

USCWA

U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

Armis Advisers Atlanta, Georgia $1.09B AUM 22.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CFD

Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return

Smartleaf Asset Management's GNOM Position: Q1 2026 in Review

Smartleaf Asset Management reduced its Global X Genomics & Biotechnology ETF (GNOM) stake by 25% in Q1 2026, selling an estimated $416 and leaving 27 shares worth $1.12K. The position accounts for ﹤0.01% of the portfolio, ranked #3099.

Smartleaf Asset Management first reported a position in GNOM in Q4 2023 and has held it in 10 quarters since. The position peaked at $187K in Q3 2025. 40 funds tracked by Wall St. Rank hold GNOM as of Q1 2026.

Smartleaf Asset Management held 27 shares of Global X Genomics & Biotechnology ETF worth $1.12K as of Q1 2026.
Smartleaf Asset Management sold 9 Global X Genomics & Biotechnology ETF shares in Q1 2026, an estimated $416.
Global X Genomics & Biotechnology ETF made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #3099 holding.
Smartleaf Asset Management first reported a position in Global X Genomics & Biotechnology ETF in Q4 2023 and has held it in 10 quarters since.
Smartleaf Asset Management's Global X Genomics & Biotechnology ETF position peaked at $187K in Q3 2025.
40 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.